Nippon India Pharma Fund-Growth Plan-Growth Option Invest Now
Fund Manager: Sailesh Raj Bhan    |     Equity: Sectoral-Pharma and Healthcare    |     S&P BSE Healthcare TRI

429.0559 1.87 (0.44 %)

NAV as on 26-04-2024

7,125.28 Cr

AUM as on 31-03-2024

Rtn ( Since Inception )

20.79%

Inception Date

Jun 01, 2004

Expense Ratio

1.83%

Fund Status

Open Ended Scheme

Min. Investment

5,000

Min. Topup

1,000

Min. SIP Amount

100

Risk Status

very high

Investment Objective : The scheme seeks to generate consistent returns by investing in equity / equity related or fixed income securities of pharma and other associated companies.